MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MiR-378 promoted cell proliferation and inhibited apoptosis by enhanced stem cell properties in chronic myeloid leukemia K562 cells

Published:2019-04 Issue: Volume:112 Page:108623
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Ma Jichun,Wu Dehong,Yi Jing,Yi Yunyun,Zhu Xin^ORCID,Qiu Hongchun,Kong Rong,Lin Jiang,Qian Jun,Deng Zhaoqun

Funder

National Natural Science foundation of China

Medical Innovation Team of Jiangsu Province

Six talent peaks project in Jiangsu Province

“Liu Ge Yi Gong Cheng” of Jiangsu Province

China Postdoctoral Science Foundation funded project

youth medical talents project of “Ke Jiao Qiang Wei” project of Jiangsu province

Zhenjiang Clinical Research Center of Hematology

Social Development Foundation of Zhenjiang

Social Development Foundation of Kunshan

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference37 articles.

1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;NEJM N. Engl. J. Med.,2015

2. Treatment options for patients with chronic myeloid leukemia who are resistant to or unable to tolerate imatinib;Stein;Clin. Ther.,2010

3. Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase;Fava;Blood,2009

4. The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review);Di;Oncol. Rep.,2016

5. Immature CML cells implement a BMP autocrine loop to escape TKI treatment;Grockowiak;Blood,2017

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors;Expert Opinion on Pharmacotherapy;2024-01-22

2. Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia;International Journal of Molecular Sciences;2023-11-23

3. Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways;Annals of Hematology;2023-08-01

4. microRNA-based Genetic Therapy in Leukemia: Properties, Delivery, and Experimental Models;Current Gene Therapy;2023-08

5. Non-Coding RNAs Are Implicit in Chronic Myeloid Leukemia Therapy Resistance;International Journal of Molecular Sciences;2022-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3